Publicaciones en las que colabora con Olga Pacios Santamaría (20)
2024
-
Improving phage therapy by evasion of phage resistance mechanisms
JAC-Antimicrobial Resistance, Vol. 6, Núm. 1
-
Mitomycin C as an Anti-Persister Strategy against Klebsiella pneumoniae: Toxicity and Synergy Studies
Antibiotics, Vol. 13, Núm. 9
-
Regulation of anti-phage defense mechanisms by using cinnamaldehyde as a quorum sensing inhibitor
Frontiers in Microbiology, Vol. 15
2023
-
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923
-
Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages
Frontiers in Microbiology, Vol. 14
-
Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae
Microbiology Spectrum, Vol. 11, Núm. 2
-
Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
Scientific Reports, Vol. 13, Núm. 1
2022
-
Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281
-
Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3
-
Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection
Frontiers in Microbiology, Vol. 12
-
Phenotypic and genomic comparison of klebsiella pneumoniae lytic phages: Vb_kpnm-vac66 and vb_kpnm-vac13
Viruses, Vol. 14, Núm. 1
-
Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2
Microbiology spectrum, Vol. 10, Núm. 5, pp. e0239822
-
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
Scientific Reports, Vol. 12, Núm. 1
2021
-
Crispr-cas, a revolution in the treatment and study of eskape infections: Pre-clinical studies
Antibiotics, Vol. 10, Núm. 7
-
Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 9
2020
-
(p)ppGpp and its role in bacterial persistence: New challenges
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 10
-
Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae
Microbial Genomics, Vol. 6, Núm. 5, pp. 1-18
-
Strategies to combat multidrug-resistant and persistent infectious diseases
Antibiotics, Vol. 9, Núm. 2
-
Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
Frontiers in Microbiology, Vol. 11
-
Viral related tools against SARS-CoV-2
Viruses, Vol. 12, Núm. 10